A follow-up survey conducted by the National Comprehensive Cancer Network (NCCN) has revealed that though shortages of chemotherapy drugs are continuing, they are having little to no impact on mesothelioma patients and others diagnosed with other cancers. Experts attribute this to the adoption of strict protocols and strategies regarding the use of available resources. Chemotherapy Drug Shortages
The International Association for the Study of Lung Cancer held its 2023 World Conference on Lung Cancer last week, and much of the information presented focused on discoveries in malignant mesothelioma. One clinical trial’s results were presented focused on the importance of dendritic cells and how they can be leveraged to stimulate immune responses.
Dr. Mohamed E. Abazeed is a radiation oncologist and scientist dedicated to improving outcomes for patients with lung cancer and other tumors, including pleural mesothelioma. He is the Co-Leader of the Lung Cancer Program at the Robert H. Lurie Comprehensive Cancer Center and an active member of the Translational Research in Solid Tumors (TRIST) program
Dr. Momen Wahidi is an internationally respected expert in interventional pulmonology and bronchoscopy with a special interest in patients with lung cancer and pleural diseases, including pleural mesothelioma and interstitial lung disease. He is the Medical Director for the Canning Thoracic Institute as well as a Professor of Medicine at Northwestern’s Feinberg School of Medicine.
Dr. Jyoti D. Patel is a thoracic oncologist and former professor of medicine at the Robert H. Lurie Comprehensive Cancer Center and Northwestern University Medical School. As Director of Thoracic Oncology, she oversaw all lung cancer clinical and research activities at the facility and was instrumental in developing clinical guidelines for the treatment of lung
Jennifer W. Carlisle, MD, is a medical oncologist at the Winship Cancer Institute at Emory University Hospital. She provides care for patients diagnosed with lung cancer, malignant pleural mesothelioma, and thymic cancers, while also advancing clinical trials, collaborating on detailed immunologic correlative studies, and teaching medical students, residents, and fellows as an Associate Professor. Education
Dr. Ticiana Leal is a thoracic medical oncologist in Atlanta specializing in the care of patients diagnosed with malignant pleural mesothelioma, lung cancer, and thymic malignancies. She is the Director of the Thoracic Medical Oncology Program at the Winship Cancer Institute of Emory University Hospital. Winship Cancer Institute is the only NCI-designated comprehensive cancer center
Dr. Frederic J. Kaye is an oncologist and hematologist, specializing in thoracic malignancies, including lung cancer and pleural mesothelioma. He is a professor of medicine and medical director of the thoracic oncology program at the University of Florida Health, and the director of the lung cancer center within the division of hematology and oncology at the University
Dr. Alan Dal Pra is a radiation oncologist who uses advanced radiation therapy tools to treat patients diagnosed with thoracic cancers, including lung cancer and pleural mesothelioma. He is the Medical Director of Radiation Oncology and part of the multidisciplinary team at the Sylvester Comprehensive Cancer Center at the University of Miami Health System in
Dr. Villamizar is a cardiothoracic surgeon, thoracic surgeon, and thoracic surgical oncologist at the Sylvester Comprehensive Cancer Center and assistant professor at the University of Miami Medical School in Miami, Florida. He specializes in treating lung cancer, pleural mesothelioma, and other thoracic cancers with the most up-to-date surgical techniques and treatment modalities. Education and Career